The 23-valent polysaccharide vaccine prevents...

The 23-valent polysaccharide vaccine prevents pneumococcal pneumonia and reduces associated mortality in nursing home residents in Japan

Abstract

Commentary on: MaruyamaTTaguchiONiedermanMS. Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial. BMJ 2010;340:c1004.

Authors

Loeb M

Journal

BMJ Evidence-Based Medicine, Vol. 15, No. 4,

Publisher

BMJ

Publication Date

August 1, 2010

DOI

10.1136/ebm1077

ISSN

2515-446X

Associated Experts

Mark Loeb

Professor, Faculty of Health Sciences

Visit profile

Labels